Subscribe To
Lamar advertising: 6 reasons to be bullish but one big risk, hold
Lamar Advertising shares have fallen 14% in 2023 due to a rise in interest rates and a slowdown in advertising. Despite the near-term weakness, LAMR i...
October 9, 2023, 1:59 am
Cme group: my favorite financial dividend stock
CME Group stands out as a resilient financial dividend stock, capitalizing on market volatility and avoiding credit risks faced by many regional banks...
October 8, 2023, 6:14 am
Clearwater paper: set to benefit from industry tailwinds
Clearwater Paper Corporation has historically been an average to below average business with low and volatile returns on invested capital. The company...
October 6, 2023, 11:14 pm
3 top-ranked stocks shrugging off market woes
Stocks displaying relative strength are common targets of investors who like to ride momentum, inserting themselves into ...
October 6, 2023, 9:02 pm
Ingevity corporation: the risk to reward is currently favorable
Ingevity Corporation has seen declines in price due to recent earnings and balance sheet risks. Despite the leveraged balance sheet, Ingevity's divers...
October 6, 2023, 1:56 pm
Ups: moving to a buy on this 4% yield stock as fundamentals bottom
UPS stock has corrected 15% since my previous article due to lower demand and Teamster contract headwinds, but volume declines should become less bad ...
October 6, 2023, 12:20 pm
Global ship lease: buy the dip on the common, sell the preferred
The shipping industry is volatile and unpredictable, but investing in companies with a forward backlog, such as GSL, improves stability and cash flow ...
October 6, 2023, 10:45 am
Why nuvalent stock skyrocketed 35% this week
Nuvalent announced favorable preliminary data from a phase 1 trial indicating its drug NVL-655 was well...
October 5, 2023, 7:13 pm
Here's why you should retain glaukos (gkos) stock for now
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial result...
October 5, 2023, 9:01 am
Bluelinx: this time looks different
BlueLinx is a prominent player in the building materials distribution industry in the US, serving a wide range of customers in residential and commerc...
October 5, 2023, 2:28 am
Trip.com: favorable tailwinds in play, initiate a buy
Trip.com has benefited from travel recovery after the reopening of the lockdown restrictions in China last year. Domestic travel in China is expected ...
October 5, 2023, 12:20 am
3 insurance stocks with more than 25% ytd gains to buy
Banking on strong fundamentals and benefiting from a favorable macro backdrop, KNSL, NMIH, and PRI have...
October 4, 2023, 2:16 pm
3 top fertilizer stocks to buy from a promising industry
Strong demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry ...
October 4, 2023, 9:46 am
L3harris: trading at a discount despite favorable competitive positioning and m&a upside
Recent geopolitical shifts to boost global military spending, providing an attractive investment case for the entire defense sector, with most of the ...
October 4, 2023, 5:57 am
Pey: targeting dividend growth and high yield
Invesco's High Yield Equity Dividend Achievers ETF targets 50 stocks that have increased their annual dividend payment for at least 10 years. While th...
October 4, 2023, 3:52 am
Buy these 3 stocks for fortress balance sheets
Companies with favorable balance sheet characteristics are better equipped to weather downturns, can pu...
October 3, 2023, 5:17 pm
4 must-have retail stocks for your holiday shopping cart
Retailers such as Urban Outfitters (URBN), Ross Stores (ROST), Walmart (WMT) and Boot Barn Holdings (BOOT) look well-poised to tap ...
October 3, 2023, 12:46 pm
Mccormick (mkc) q3 earnings match estimates, eps view up
McCormick's (MKC) third-quarter fiscal 2023 results reflect gains from higher pricing, favorable demand...
October 3, 2023, 11:17 am
Should you buy everest group (eg) for better returns now?
Everest Group (EG) stands to gain from new business growth, strong renewal retention, continued favorable...
October 3, 2023, 11:16 am
Navigating acumen's alzheimer's risk and reward
Acumen Pharmaceuticals' ACU193 shows promise as a potential treatment for early-stage Alzheimer's Disease, targeting amyloid beta oligomers with a mor...
October 3, 2023, 11:03 am